Exploring the potential of Arbacia lixula coelomic fluid peptides as cell cycle and angiogenesis inhibitor for triple-negative breast cancer therapy: In silico study
Context: Triple-negative breast cancer (TNBC) is a breast malignancy with a high degree of heterogeneity. Currently, low treatment efficacy remains a challenge in dealing with TNBC. Arbacia lixula has the potential to become a new therapeutic agent in TNBC. Aims: To analyze the toxicity, allergen...
Gorde:
| Egile Nagusiak: | , , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
GarVal Editorial Ltda.
2025-01-01
|
| Saila: | Journal of Pharmacy & Pharmacognosy Research |
| Gaiak: | |
| Sarrera elektronikoa: | https://jppres.com/jppres/pdf/vol13/jppres24.1991_13.1.242.pdf |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|